Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 58 citing articles:

A biological definition of neuronal α-synuclein disease: towards an integrated staging system for research
Tanya Simuni, Lana M. Chahine, Kathleen L. Poston, et al.
The Lancet Neurology (2024) Vol. 23, Iss. 2, pp. 178-190
Closed Access | Times Cited: 251
Cognitive effects of Lewy body pathology in clinically unimpaired individuals
Sebastian Palmqvist, Marcello Rossi, Sara Hall, et al.
Nature Medicine (2023) Vol. 29, Iss. 8, pp. 1971-1978
Open Access | Times Cited: 80
Performance of a seed amplification assay for misfolded alpha-synuclein in cerebrospinal fluid and brain tissue in relation to Lewy body disease stage and pathology burden
Giuseppe Mario Bentivenga, Angela Mammana, Simone Baiardi, et al.
Acta Neuropathologica (2024) Vol. 147, Iss. 1
Open Access | Times Cited: 37
Investigating alpha‐synuclein co‐pathology in Alzheimer's disease by means of cerebrospinal fluid alpha‐synuclein seed amplification assay
G. Bellomo, Andrea Toja, Federico Paolini Paoletti, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 4, pp. 2444-2452
Open Access | Times Cited: 35
CSF α-synuclein seed amplification kinetic profiles are associated with cognitive decline in Parkinson’s disease
Kathrin Brockmann, Stefanie Lerche, Simone Baiardi, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 29
Plasma proteomics identify biomarkers predicting Parkinson’s disease up to 7 years before symptom onset
Jenny Hällqvist, Michael Bartl, Mohammed Dakna, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 28
Detecting Misfolded α‐Synuclein in Blood Years before the Diagnosis of Parkinson's Disease
Annika Kluge, Eva Schaeffer, Josina Bunk, et al.
Movement Disorders (2024) Vol. 39, Iss. 8, pp. 1289-1299
Open Access | Times Cited: 25
Improving protocols for α-synuclein seed amplification assays: analysis of preanalytical and analytical variables and identification of candidate parameters for seed quantification
Angela Mammana, Simone Baiardi, Marcello Rossi, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2024) Vol. 62, Iss. 10, pp. 2001-2010
Open Access | Times Cited: 15
Clinicopathological correlation of cerebrospinal fluid alpha‐synuclein seed amplification assay in a behavioral neurology autopsy cohort
Niyatee Samudra, D. Luke Fischer, Steven Lenio, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 5, pp. 3334-3341
Open Access | Times Cited: 13
α-Synuclein seed amplification technology for Parkinson’s disease and related synucleinopathies
Claudio Soto
Trends in biotechnology (2024) Vol. 42, Iss. 7, pp. 829-841
Closed Access | Times Cited: 10
Sensitivity and specificity of a seed amplification assay for diagnosis of multiple system atrophy: a multicentre cohort study
Yihua Ma, Carly M. Farris, Sandrina Weber, et al.
The Lancet Neurology (2024) Vol. 23, Iss. 12, pp. 1225-1237
Closed Access | Times Cited: 10
Toward a biological definition of neuronal and glial synucleinopathies
Claudio Soto, Brit Mollenhauer, Oskar Hansson, et al.
Nature Medicine (2025)
Closed Access | Times Cited: 1
Evidence for alpha-synuclein aggregation in older individuals with hyposmia: a cross-sectional study
Kenneth Marek, David Russell, Luis Concha‐Marambio, et al.
EBioMedicine (2025) Vol. 112, pp. 105567-105567
Open Access | Times Cited: 1
α-Synuclein Seed Amplification Assay Amplification Parameters and the Risk of Progression in Prodromal Parkinson Disease
David G. Coughlin, Ben Shifflett, Carly M. Farris, et al.
Neurology (2025) Vol. 104, Iss. 5
Closed Access | Times Cited: 1
Methods to Discover and Validate Biofluid-Based Biomarkers in Neurodegenerative Dementias
Charlotte E. Teunissen, Leighann Kimble, Sherif Bayoumy, et al.
Molecular & Cellular Proteomics (2023) Vol. 22, Iss. 10, pp. 100629-100629
Open Access | Times Cited: 22
Neuronal alpha-Synuclein Disease integrated staging system performance in PPMI, PASADENA, and SPARK baseline cohorts
Tien Dam, Gennaro Pagano, Michael C. Brumm, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 8
Pathological α-synuclein detected by real-time quaking-induced conversion in synucleinopathies
Juan Huang, Xingxing Yuan, Lin Chen, et al.
Experimental Gerontology (2024) Vol. 187, pp. 112366-112366
Open Access | Times Cited: 7
A review on the new age methodologies for early detection of Alzheimer's and Parkinson's disease
Nabanita Ghosh, Krishnendu Sinha, Parames C. Sil
Basic & Clinical Pharmacology & Toxicology (2024) Vol. 134, Iss. 5, pp. 602-613
Open Access | Times Cited: 6
Opportunities and Pitfalls of REM Sleep Behavior Disorder and Olfactory Dysfunction as Early Markers in Parkinson’s Disease
Beatrice Orso, Sarah Brosse, Johannes Frasnelli, et al.
Journal of Parkinson s Disease (2024) Vol. 14, Iss. s2, pp. S275-S285
Open Access | Times Cited: 6
Lysosomal and synaptic dysfunction markers in longitudinal cerebrospinal fluid of de novo Parkinson’s disease
Michael Bartl, Johanna Nilsson, Mohammed Dakna, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 6
Ethical Considerations for Identifying Individuals in the Prodromal/Early Phase of Parkinson’s Disease: A Narrative Review
Eva Schaeffer, Rezzak Yılmaz, Erik K. St. Louis, et al.
Journal of Parkinson s Disease (2024) Vol. 14, Iss. s2, pp. S307-S319
Open Access | Times Cited: 5
Subregional analysis of striatum iron in Parkinson’s disease and rapid eye movement sleep behaviour disorder
Erind Alushaj, Dimuthu Hemachandra, Alan Kuurstra, et al.
NeuroImage Clinical (2023) Vol. 40, pp. 103519-103519
Open Access | Times Cited: 11
CSF markers of neurodegeneration Alzheimer’s and Lewy body pathology in isolated REM sleep behavior disorder
Amaia Muñoz‐Lopetegi, Simone Baiardi, Mircea Balasa, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 4
A quantitative Lewy-fold-specific alpha-synuclein seed amplification assay as a progression marker for Parkinson’s disease
Alexander Bernhardt, Sebastian Longen, Svenja V. Trossbach, et al.
Acta Neuropathologica (2025) Vol. 149, Iss. 1
Open Access
Seeding amplification assay: Limitations and insights for enhanced clinical and research applications
Ilham Y. Abdi, Sara A Hashish, Omar M. A. El‐Agnaf
Journal of Parkinson s Disease (2025)
Open Access
Page 1 - Next Page

Scroll to top